These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2894999)

  • 21. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NMDA antagonists MK801 and CPP disrupt compensation for unilateral labyrinthectomy in the guinea pig.
    Smith PF; Darlington CL
    Neurosci Lett; 1988 Dec; 94(3):309-13. PubMed ID: 3060764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epileptiform bursts elicited in CA3 hippocampal neurons by a variety of convulsants are not blocked by N-methyl-D-aspartate antagonists.
    Neuman R; Cherubini E; Ben-Ari Y
    Brain Res; 1988 Sep; 459(2):265-74. PubMed ID: 2902900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices.
    Fletcher EJ; Lodge D
    Eur J Pharmacol; 1988 Jun; 151(1):161-2. PubMed ID: 2901361
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of N-methyl-D-aspartate antagonists on the cough reflex.
    Kamei J; Tanihara H; Igarashi H; Kasuya Y
    Eur J Pharmacol; 1989 Sep; 168(2):153-8. PubMed ID: 2691260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological characterization.
    Balázs R; Hack N; Jørgensen OS; Cotman CW
    Neurosci Lett; 1989 Jul; 101(3):241-6. PubMed ID: 2549463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK-801 powerfully protects against N-methyl aspartate neurotoxicity.
    Olney J; Price M; Salles KS; Labruyere J; Frierdich G
    Eur J Pharmacol; 1987 Sep; 141(3):357-61. PubMed ID: 3311770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization.
    Lysko PG; Cox JA; Vigano MA; Henneberry RC
    Brain Res; 1989 Oct; 499(2):258-66. PubMed ID: 2572298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of febrile seizures in epileptic chicks by N-methyl-D-aspartate receptor antagonists.
    Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
    Can J Physiol Pharmacol; 1990 Jan; 68(1):84-8. PubMed ID: 2158387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
    Sanger DJ; Jackson A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.
    Tan S; Kirk RC; Abraham WC; McNaughton N
    Psychopharmacology (Berl); 1989; 98(4):556-60. PubMed ID: 2505299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum.
    Shannon HE; Sawyer BD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):518-23. PubMed ID: 2572691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
    Holohean AM; Hackman JC
    Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.